This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a cyclopropylamine group and difluorophenyl ring, makes it a valuable intermediate in the creation of molecules targeting central nervous system disorders. Researchers explore its potential in designing compounds with activity against neurological conditions such as depression, anxiety, or neurodegenerative diseases. Additionally, it may serve as a building block in the development of selective enzyme inhibitors or receptor modulators, contributing to the advancement of therapeutic agents with improved efficacy and reduced side effects. Its application is largely confined to preclinical studies, where it aids in the discovery of new bioactive molecules.